UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053791
Receipt number R000061394
Scientific Title Pilot study to create a comfortable treatment space using an airflow system with a simulated window
Date of disclosure of the study information 2024/03/06
Last modified on 2024/03/06 15:49:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pilot study to create a comfortable treatment space using an airflow system with a simulated window

Acronym

Pilot study to create a comfortable treatment space using an airflow system with a simulated window

Scientific Title

Pilot study to create a comfortable treatment space using an airflow system with a simulated window

Scientific Title:Acronym

Pilot study to create a comfortable treatment space using an airflow system with a simulated window

Region

Japan


Condition

Condition

cancer

Classification by specialty

Medicine in general Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to provide exploratory insights into the impact of a comfortable treatment and recuperation space on patient symptoms and emotions and the factors that contribute to optimal personalization of the space.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of ESAS-J score change before and after 1 day of installation of air blowing system with pseudo window

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

The intensity of symptoms will be evaluated by the Edmonton Symptom Assessment System Japanese version (ESAS-r-J) at any given time on the day before the installation of the air blowing system with pseudo windows (Day 1). In addition, "sense of release, healing, enjoyment, and satisfaction" will be evaluated by Numerical Rating Scale (NRS). In addition, autonomic nervous system function will be measured by having subjects wear a smartwatch on their wrists and a Sleep Scan (Paramount Bed, Japan) will be placed under their bedding. Twenty-four hours after the initial evaluation (Day 2), a ventilation system with a pseudo-window will be installed. The patients will be evaluated by ESAS-r-J and NRS at the time of installation of the system (Day 2) and 24 hours after installation (Day 3), and their autonomic nervous system function will be measured by TAS9 view. The smartwatch and sleep scan will be worn or installed continuously from any time on the day before the installation of the airflow system with a pseudo-window (Day 1) to the end of the intervention (Day 3). The airflow from the ventilation system will be directed to the subject's face, and the air volume will be set to moderate in principle, but the subject can adjust it according to his/her own preferences. In principle, the video images will be played in accordance with the time of day using the application equipped with the pseudo-window, but if desired and with the cooperation of family members, etc., the video images can be played at home or any other desired location.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients over 18 years old
Cancer patients who are hospitalized for more than 7 days
Those who are hospitalized in an environment that does not allow them to enjoy the view from the window.
Those who are able to answer the questionnaire in writing or orally.

Key exclusion criteria

Patients under the age of 18
Non-cancer patients
Those who are hospitalized for less than 7 days
Those who are hospitalized in an environment where they can enjoy the scenery from the window.
Those with cognitive decline to the extent that they are unable to respond to the questionnaire.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name Yoshiaki
Middle name
Last name Okamoto

Organization

Ashiya Municipal Hospital

Division name

Department of Pharmacy

Zip code

659-8502

Address

39-1, Asahigaoka-cho, Ashiya, Hyogo

TEL

0797-31-2156

Email

okamoysh@phs.osaka-u.ac.jp


Public contact

Name of contact person

1st name Kazuyuki
Middle name
Last name Niki

Organization

Ashiya Municipal Hospital

Division name

Department of Pharmacy

Zip code

659-8502

Address

39-1, Asahigaoka-cho, Ashiya, Hyogo

TEL

0797-31-2156

Homepage URL


Email

k-niki@phs.osaka-u.ac.jp


Sponsor or person

Institute

Ashiya Municipal Hospital

Institute

Department

Personal name



Funding Source

Organization

self-procurement

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ashiya Municipal Hospital Ethics Review Committee

Address

39-1, Asahigaoka-cho, Ashiya, Hyogo

Tel

0797-31-2156

Email

k-niki@phs.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 01 Month 10 Day

Date of IRB

2024 Year 01 Month 25 Day

Anticipated trial start date

2024 Year 03 Month 06 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 03 Month 06 Day

Last modified on

2024 Year 03 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061394


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name